Vanderbilt researchers have discovered another acid resistance mechanism for UTI-causing E. coli, laying the foundation for targeted antibacterial therapies.

Vanderbilt's James Crowe Jr., MD, was among those to receive 2023 Advocacy Awards from Research!America at the biomedical research advocacy organization’s annual awards program in Washington, D.C.

Vanderbilt was part of a multi-center team that resurrected a “dead antibody” to reveal the mysteries of cytochrome c, a versatile protein that is an essential part of the cell’s energy-generating capacity, and of life itself.

Tadashi Inagami, PhD, DSc, Vanderbilt University Professor of Biochemistry, emeritus, who helped characterize the biochemical basis for hypertension, heart failure and vascular disease, died in Pittsburgh, Pennsylvania, March 13 after a brief illness. He was 92.

A Vanderbilt study found that prostate cancer polygenic risk score has limited utility for enhancing prostate cancer screening.

“The NPH Protocol exemplifies multiple disciplines working together to improve the lives of patients and their caregivers.”